Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)

42.50
Delayed Data
As of Dec 10
 +0.97 / +2.34%
Today’s Change
35.41
Today|||52-Week Range
74.50
-2.25%
Year-to-Date
No recent news for Ultragenyx Pharmaceutical Inc.

Today’s Trading

Previous close41.53
Today’s open41.36
Day’s range41.02 - 42.54
Volume380,024
Average volume (3 months)564,534
Market cap$2.5B
Data as of 4:00pm ET, 12/10/2019

Growth & Valuation

Earnings growth (last year)+44.24%
Earnings growth (this year)-76.13%
Earnings growth (next 5 years)-89.09%
Revenue growth (last year)+1,871.48%
P/E ratioNM
Price/Sales42.03
Price/Book3.57

Competitors

 Today’s
change
Today’s
% change
ARQLArQule Inc+0.25+1.27%
ARNAArena Pharmaceutical...-0.51-1.04%
FOLDAmicus Therapeutics ...+0.03+0.26%
RARXRa Pharmaceuticals I...+0.17+0.36%
Data as of 4:00pm ET, 12/10/2019

Financials

Next reporting dateFebruary 18, 2020
EPS forecast (this quarter)-$1.63
Annual revenue (last year)$51.5M
Annual profit (last year)-$197.6M
Net profit margin-383.75%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Novato, California

Forecasts